ZA805652B - Compounds having antitumour properties - Google Patents

Compounds having antitumour properties

Info

Publication number
ZA805652B
ZA805652B ZA00805652A ZA805652A ZA805652B ZA 805652 B ZA805652 B ZA 805652B ZA 00805652 A ZA00805652 A ZA 00805652A ZA 805652 A ZA805652 A ZA 805652A ZA 805652 B ZA805652 B ZA 805652B
Authority
ZA
South Africa
Prior art keywords
compounds
antitumour properties
antitumour
properties
Prior art date
Application number
ZA00805652A
Other languages
English (en)
Inventor
B Cain
G Atwell
B Baguley
W Denny
Original Assignee
New Zealand Dev Finance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Dev Finance filed Critical New Zealand Dev Finance
Publication of ZA805652B publication Critical patent/ZA805652B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA00805652A 1979-09-14 1980-09-12 Compounds having antitumour properties ZA805652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ19157779 1979-09-14

Publications (1)

Publication Number Publication Date
ZA805652B true ZA805652B (en) 1981-09-30

Family

ID=19918920

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00805652A ZA805652B (en) 1979-09-14 1980-09-12 Compounds having antitumour properties

Country Status (6)

Country Link
US (1) US4472582A (xx)
EP (1) EP0025705B1 (xx)
JP (1) JPS5651457A (xx)
AU (1) AU534608B2 (xx)
DE (1) DE3063905D1 (xx)
ZA (1) ZA805652B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651457A (en) * 1979-09-14 1981-05-09 Dev Finance Antitumoral compound and its manufacture
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
EP0039224B1 (en) * 1980-04-28 1984-06-27 Development Finance Corporation Of New Zealand Compound having antitumour properties
NZ198115A (en) * 1981-08-21 1985-05-31 New Zealand Dev Finance 9-anilinoacridines;pharmaceutical compositions
NZ199887A (en) * 1982-03-02 1985-03-20 New Zealand Dev Finance Phenanthroline derivatives and pharmaceutical compositions
NZ200715A (en) * 1982-05-24 1986-06-11 New Zealand Dev Finance Acridine derivatives and pharmaceutical compositions containing such
NZ201084A (en) * 1982-06-25 1985-10-11 New Zealand Dev Finance 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
US4575553A (en) * 1984-06-18 1986-03-11 Bristol-Myers Company Antitumor m-AMSA analog
AU2010214095B2 (en) * 2009-02-11 2015-12-24 Merck Patent Gmbh Novel amino azaheterocyclic carboxamides
EP3125891A4 (en) * 2014-03-31 2017-08-09 Mirx Pharmaceuticals, LLC Novel hdmx inhibitors and their use for cancer treatment
US10548911B2 (en) 2014-06-16 2020-02-04 University Of Rochester Small molecule anti-scarring agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651457A (en) * 1979-09-14 1981-05-09 Dev Finance Antitumoral compound and its manufacture
EP0039224B1 (en) * 1980-04-28 1984-06-27 Development Finance Corporation Of New Zealand Compound having antitumour properties

Also Published As

Publication number Publication date
EP0025705A1 (en) 1981-03-25
US4472582A (en) 1984-09-18
JPS5651457A (en) 1981-05-09
AU534608B2 (en) 1984-02-09
AU6238080A (en) 1981-03-19
DE3063905D1 (en) 1983-07-28
EP0025705B1 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
MY8500010A (en) Antitumour agent
IL59287A0 (en) 14-methoxymorphinan-6-one compounds
ZA805652B (en) Compounds having antitumour properties
ZA807296B (en) Novel mercaptoorganosiloxanes
GB2125037B (en) 2-acetoxymethyl-penam compounds
JPS5679692A (en) Novel pyridothienotriazines
ZA806146B (en) Heterocyclici compounds
GB2056903B (en) Vacuum-moulded articles
JPS567790A (en) Novel penicillinn1*11dioxide compound
DE3164407D1 (en) Compound having antitumour properties
JPS565463A (en) Novel 44aroylimidazolee22ones
JPS55130985A (en) Novel betaatrialkoxysilylthiopropionamide
ZA802765B (en) Novel compounds
JPS5699462A (en) Novel hydroxyphenylketone
GB2047708B (en) Butyloctyl-magnesium compounds
IL61133A0 (en) 6-methylene-morphinan compounds
JPS55147293A (en) Novel thiazolinoazetidinone compound
GB2065105B (en) Dibenzazepines
ZA807948B (en) 2-oxybenzimidazoline compounds
GB2111983B (en) Cyclopent-4-en-5-olone compounds
DE3064156D1 (en) 1-halo-4-decene compounds
JPS55162734A (en) 11aamethanootxa compounds
JPS55164689A (en) Novel penicillinn1* 11dioxide compound
PH17042A (en) Thiadiazolo-and oxadiazolotetrahydroisoquinoline compounds